Mangrove Partners Corcept Therapeutics Inc Transaction History
Mangrove Partners
- $691 Million
- Q2 2025
A detailed history of Mangrove Partners transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Mangrove Partners holds 9,499 shares of CORT stock, worth $837,336. This represents 0.1% of its overall portfolio holdings.
Number of Shares
9,499Holding current value
$837,336% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
467Shares Held
82.8MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.46 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$853 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$681 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$552 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$341 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $9.44B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...